Andere Sprachen BioSig Technologies, Inc.

Aktien

A401PF

US09073N3008

BSGM

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 18.04.2024			% 5 Tage	% 1. Jan.
1,54 ^USD	-5,52 %		+3,36 %	-67,58 %

16.04.	BioSig Technologies, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
28.02.	Biosig Technologies, Inc. gibt den Rücktritt von Kenneth L. Londoner als Chief Executive Officer bekannt	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

BioSig Technologies : Annual report pursuant to Section 13 and 15(d)	16.04.
BioSig Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	16.04.
BioSig Engages Consulting Firm for Business Model Strategies	04.04.
BioSig Technologies : Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT	02.04.
BioSig Technologies : Failure to Satisfy Listing Rule - Form 8-K	18.03.
BioSig Technologies Inc. Issues Promissory Note to an Investor for $500,000	12.03.
BioSig Technologies, Inc. announced that it has received $0.5 million in funding	07.03.
Biosig Technologies, Inc. Announces Resignation of Kenneth L. Londoner as Chief Executive Officer	28.02.
BioSig Technologies, Inc. Announces Executive Changes	28.02.
Steve Buhaly Resigns as Chief Financial Officer of Biosig Technologies, Inc	21.02.
Biosig Technologies, Inc. Announces Directorate Resignations	21.02.
BioSig Announces Reduction of its Workforce	20.02.
BioSig Announces Reduction of its Workforce	20.02.
BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases	06.02.
Biosig Technologies, Inc. Commences Workforce Reduction Consisted of the Departure of Sixteen Employees	01.02.
BioSig Technologies, Inc. Announces Executive Departures	01.02.
BioSig Technologies Undertaking 1-for-10 Reverse Stock Split	31.01.
BioSig Announces Reverse Stock Split	31.01.
BioSig Announces Reverse Stock Split	31.01.
BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy	30.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen BioSig Technologies, Inc.

Aktien

A401PF

US09073N3008

BSGM

Andere Sprachen

Filter